Anteilseigner
BVF Partners LP (17,88 %) Armistice Capital LLC (9,05 %) ALS Therapy Development Foundation, Inc. (5,48 %) The Vanguard Group, Inc. (2,87 %) Woodline Partners LP (2,85 %) Ensign Peak Advisors, Inc. (1,83 %) Geode Capital Management LLC (0,73 %) CM Management LLC (0,58 %) Susquehanna Financial Group LLLP (0,36 %) Renaissance Technologies LLC (0,29 %) Next Edge Capital Corp. (0,27 %) JMAC Enterprises LLC (0,24 %) Ingalls & Snyder LLC (0,21 %) SSgA Funds Management, Inc. (0,18 %) Northern Trust Investments, Inc.(Investment Management) (0,16 %) BlackRock Fund Advisors (0,11 %) Citadel Securities LLC (0,10 %) Millennium Management LLC (0,09 %) Mercer Global Advisors, Inc. (0,07 %) Charles Schwab Investment Management, Inc. (0,06 %)
Kontakt
Eledon Pharmaceuticals Inc.